by Enoch Daniel

7 minutes

How Africa Is Expanding Its Pharma Manufacturing Capabilities: 7 Key Developments To Watch In 2025

Explore 7 transformative strategies shaping Africa’s pharmaceutical industry, from local manufacturing to sustainability and innovation.

How Africa Is Expanding Its Pharma Manufacturing Capabilities: 7 Key Developments To Watch In 2025

Africa's pharmaceutical industry is undergoing a significant shift, moving away from heavy import dependence to building a strong, self-reliant sector with global significance. 

Today, in this article, we will explore 7 key strategies driving this shift across the continent! 


Strengthening Local Manufacturing: From Dependency To Self-Sufficiency

The Challenge: When we talk about Africa, it heavily relies on imported medicines, with over 70% coming from outside the continent. This dependence spikes up costs and supply challenges, which leads to limited affordable healthcare access.

The Solution: Aftica shifted its focus towards local manufacturing, which is gaining momentum. In Nigeria, the National Institute for Pharmaceutical Research & Development (NIPRD) is putting efforts to boost domestic drug production, while Kenya’s Universal Health Coverage program is focusing on growing its drug manufacturing sector.

Example: Aspen Pharmacare, South Africa’s top drug manufacturer, plays a key role in reducing import reliance by producing vaccines like those for COVID-19, improving access across the region.

Key Takeaway: By producing more medicines locally, Africa is able to create jobs, lower import expenses, and provide better healthcare access to underserved communities.


Leveraging Public-Private Partnerships (PPPs): Collaborative Solutions

The Challenge: The major problem was setting up pharmaceutical manufacturing facilities because it is too expensive and also required advanced technical expertise.

The Solution: Public-Private Partnerships or PPPs are helping the African healthcare industry to fill the gaps. For example, Rwanda teamed up with BioNTech to build an mRNA vaccine facility, bringing in funding, technology, and regulatory knowledge.

Example: The Serum Institute of India worked with South African companies to establish local vaccine production plants, promoting self-reliance across the region. 

Key Takeaway: PPPs are tracking the progress of Africa, which helps the continent to meet global standards in pharmaceutical manufacturing.


Embracing Technology And Automation

The Challenge: Manual manufacturing methods often lead to inefficiencies, mistakes, and higher costs.

The Solution: Pharmaceutical companies in Africa are turning to automation and advanced technologies like blockchain in order to improve supply chain transparency. In Ghana, technology is being utilized to monitor pharmaceutical production and logistics, making sure that the quality is maintained and cutting down on fraud.

Example: Cipla Medpro in South Africa is utilizing AI and robotics to improve the efficiency of production and maintain high-quality standards, making its operations more competitive globally.

Key Takeaway: The integration of technology will not only help in improving efficiency but will also help pharma manufacturers in Africa become trusted suppliers in the global market.


Fostering Workforce Development: Building a Skilled Talent Pool

The Challenge: The absence of specialized training in pharmaceutical manufacturing limits the ability to expand operations in different parts of Africa.

The Solution: Governments and private sectors are focusing on education and skill-building. Pharmacy Council of Nigeria is providing certification courses to train professionals in modern manufacturing techniques.

Example: The African Union’s Pharma Manufacturing Plan includes programs aimed at training young professionals, ensuring a steady flow of talent for the healthcare industry.

Key Takeaway: A well-trained and knowledgeable workforce drives operational success, improves productivity, and encourages innovation in the pharmaceutical sector.


Establishing Robust Regulatory Framework

The Challenge: Inconsistent regulations across African countries have made it difficult to attract investment.

The Solution: The African Medicines Agency (AMA), set up in 2021, is working towards standardizing regulations across the continent. This unified system is eliminating unnecessary steps and accelerating the process of drug approval. 

Example: With AMA’s support and guidance, Ethiopia has improved its drug approval process, cutting approval times by almost 40%.

Key Takeaway: A unified regulatory framework will boost investor confidence and strengthen the role of Africa in global pharmaceutical supply chains.


Prioritizing Vaccine Production: A Focus on Self-Reliance

The Challenge: Africa’s capacity to produce vaccines was severely lacking during the COVID-19 pandemic.

The Solution: Countries like Senegal and South Africa are leading the way in vaccine production. The Pasteur Institute in Dakar is set to manufacture millions of vaccines each year, including COVID-19 and other essential immunizations.

Example: A partnership between the WHO and Rwanda to build vaccine production facilities highlights Africa’s commitment to becoming a self-reliant region in healthcare.

Key Takeaway: By strengthening the production of vaccines, Africa is preparing for future pandemics and also focusing on reducing healthcare disparities across the continent.


Advancing Sustainability in Manufacturing

The Challenge: Pharmaceutical manufacturing is resource-intensive as it consumes large amounts of energy and water, producing significant pharmaceutical waste. This results in the degradation of the environment, making it crucial to adopt more sustainable practices in the industry.

The Solution: Pharma companies are adopting sustainable practices, like using solar power and implementing water recycling systems. Cipla’s plant in Uganda runs on renewable energy, setting an example for eco-friendly pharmaceutical manufacturing in Africa.

Example: Nigeria’s Green Pharma Initiative aims to reduce pharmaceutical waste by introducing innovative recycling methods and environmentally friendly production processes.

Key Takeaway: Sustainability is an ethical duty and a strategic advantage that helps pharma companies secure global partnerships and comply with international standards.


Summing It Up! 

Africa can be seen stepping up in the pharmaceutical industry. With innovation, collaboration, and smart investments, the continent is managing local healthcare challenges while establishing itself as a strong competitor in global pharma manufacturing.

For more such insightful articles, visit Pharma Now right now!

Author Profile

Enoch Daniel

Director

Comment your thoughts

Author Profile

Enoch Daniel

Director

Ad
Advertisement

You may also like

Article
Ensuring Compliance in Pharmaceutical Manufacturing: Key Regulations and Best Practices

Enoch Daniel